CN104587319A - 一种修复剖腹产疤痕的药膏 - Google Patents
一种修复剖腹产疤痕的药膏 Download PDFInfo
- Publication number
- CN104587319A CN104587319A CN201510043395.8A CN201510043395A CN104587319A CN 104587319 A CN104587319 A CN 104587319A CN 201510043395 A CN201510043395 A CN 201510043395A CN 104587319 A CN104587319 A CN 104587319A
- Authority
- CN
- China
- Prior art keywords
- parts
- cicatrix
- ointment
- quintessence oil
- cesarean
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 45
- 231100000241 scar Toxicity 0.000 title abstract description 21
- 208000032544 Cicatrix Diseases 0.000 title abstract description 3
- 230000037387 scars Effects 0.000 title abstract description 3
- 239000003814 drug Substances 0.000 claims abstract description 44
- 238000002360 preparation method Methods 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 210000000589 cicatrix Anatomy 0.000 claims description 83
- 210000000582 semen Anatomy 0.000 claims description 66
- 235000007164 Oryza sativa Nutrition 0.000 claims description 32
- 235000009566 rice Nutrition 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 19
- 230000008439 repair process Effects 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 15
- 241001057584 Myrrha Species 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000006071 cream Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 7
- 229940099259 vaseline Drugs 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 3
- 241000209094 Oryza Species 0.000 claims 6
- 230000000694 effects Effects 0.000 abstract description 21
- 230000036407 pain Effects 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 16
- 238000011282 treatment Methods 0.000 abstract description 13
- 239000000341 volatile oil Substances 0.000 abstract description 4
- 240000007311 Commiphora myrrha Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 244000291564 Allium cepa Species 0.000 abstract 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 abstract 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 241001179022 Hydnocarpus anthelminthicus Species 0.000 abstract 1
- 235000009815 Momordica Nutrition 0.000 abstract 1
- 241000218984 Momordica Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241001423217 Ormosia henryi Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 1
- 240000009022 Smilax rotundifolia Species 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 235000001053 badasse Nutrition 0.000 abstract 1
- 244000056931 lavandin Species 0.000 abstract 1
- 235000009606 lavandin Nutrition 0.000 abstract 1
- HTUMBQDCCIXGCV-UHFFFAOYSA-N lead oxide Chemical compound [O-2].[Pb+2] HTUMBQDCCIXGCV-UHFFFAOYSA-N 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 64
- 240000007594 Oryza sativa Species 0.000 description 26
- 208000027418 Wounds and injury Diseases 0.000 description 16
- 231100000614 poison Toxicity 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 16
- 206010052428 Wound Diseases 0.000 description 15
- 230000006870 function Effects 0.000 description 12
- 239000003440 toxic substance Substances 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 230000008961 swelling Effects 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 206010042674 Swelling Diseases 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 244000045947 parasite Species 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 208000002260 Keloid Diseases 0.000 description 5
- 206010023330 Keloid scar Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 210000001117 keloid Anatomy 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 230000037394 skin elasticity Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000008451 emotion Effects 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 210000000835 hypertrophic cicatrix Anatomy 0.000 description 3
- 238000002647 laser therapy Methods 0.000 description 3
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000717739 Boswellia sacra Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical class CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 235000003143 Panax notoginseng Nutrition 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000002096 anti-tetanic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 229930006739 camphene Natural products 0.000 description 2
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 229910052949 galena Inorganic materials 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 229910000464 lead oxide Inorganic materials 0.000 description 2
- XCAUINMIESBTBL-UHFFFAOYSA-N lead(ii) sulfide Chemical compound [Pb]=S XCAUINMIESBTBL-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- YEXPOXQUZXUXJW-UHFFFAOYSA-N oxolead Chemical compound [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 150000003507 terpinene derivatives Chemical class 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical class CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XVKPBYJWSA-N (1s,4r)-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound C1C[C@@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-XVKPBYJWSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical class CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Chemical class 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 206010055000 Bromhidrosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 241000037803 Coptis deltoidea Species 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010022086 Injection site pain Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Chemical class CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000002740 Muscle Rigidity Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Chemical class CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- HIGQPQRQIQDZMP-DHZHZOJOSA-N Neryl acetate Chemical class CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000522652 Ormosia <angiosperm> Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 241001501970 Prionailurus bengalensis Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 244000086363 Pterocarpus indicus Species 0.000 description 1
- 235000009984 Pterocarpus indicus Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 241000951376 Schizonepeta tenuifolia Species 0.000 description 1
- 244000296102 Selinum monnieri Species 0.000 description 1
- 235000019084 Selinum monnieri Nutrition 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 229930006722 beta-pinene Chemical class 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000000315 cryotherapy Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 229930002886 farnesol Chemical class 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000003664 filaricide agent Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Chemical class CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009442 healing mechanism Effects 0.000 description 1
- BGOFCVIGEYGEOF-UJPOAAIJSA-N helicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1C=O BGOFCVIGEYGEOF-UJPOAAIJSA-N 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000037233 inflexible joints Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000008127 lead poisoning Diseases 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- HIGQPQRQIQDZMP-FLIBITNWSA-N neryl acetate Chemical class CC(C)=CCC\C(C)=C/COC(C)=O HIGQPQRQIQDZMP-FLIBITNWSA-N 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 150000007823 ocimene derivatives Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 229930002600 steroidal saponin Natural products 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Chemical class CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical class C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种修复剖腹产疤痕的药膏及其制备方法,取下述重量配比的主要原料药制备而成:荆芥10-15,金银花10-15,花榈木8-12,艾叶10-15,没药9-16,黄连4-9,蛇床子8-12,密陀僧5-10,大枫子7-12,木鳖子9-15,葱白6-12,土茯苓5-10,醒目薰衣草精油0.5-1.2,橙花精油0.6-1.0。本发明疗效显著,治疗费用低、无痛苦、治疗时间较短、无副作用。
Description
技术领域
本发明涉及中医中药领域,特别是涉及一种修复剖腹产疤痕的药膏及其制备方法。
背景技术
剖腹产疤痕是手术后伤口上留下的痕迹,一般呈白色或灰白色,光滑、质地坚硬。大约在手术刀口结疤二至三周后,疤痕开始增生,此时局部发红、发紫、变硬,并突出皮肤表面。疤痕处有新生的神经末梢,但其是杂乱无章的。疤痕的形成和肤色及体质有关,肤色越深就越容易有疤痕体质。不管是外伤或手术,只要伤口深入真皮层,人体就会产生疤痕组织,将伤口连结起来。因为人体对于伤口愈合的机制不同,如果伤口在表皮层,属于再生机制,表皮会长出和原来一样的组织细胞,所以不会留下疤痕。然而当皮层伤及真皮层,则愈合机制就属于修复系统,人体会产生疤痕组织来连结伤口,而产生愈合后留下的疤痕。疤痕的出现首当其冲就是影响外观,剖腹产疤痕的美丑主要与伤口的张力有关,剖腹的伤口如果刚好跟皮肤纹路平行,疤痕可以隐藏在纹路中,成熟后只会留下淡淡一条线,几乎看不见,所以横切的剖腹产伤口会比较美观。相反地,如果伤口刚好跟皮肤纹路垂直,疤痕就会特别难看。
疤痕的治疗方法有:手术治疗、药物治疗、压迫治疗、激光治疗、放射、冷冻、硅胶贴治疗。常见的治疗方法有(1)手术去疤。手术可以去除肚皮上的增生性疤痕和疤痕瘤,也能去除关节附近妨碍行动的疤痕。它通常与类固醇注射和硅胶贴片后续治疗联合应用。单独应用时有可能造成异常疤痕的再生。(2)固醇注射。皮质类固醇注射是增生性疤痕和疤痕瘤的一线治疗方案。每4-6周的病灶内注射需要进行几个月或者直到疤痕变平。注射时的疼痛经常影响患者的依从性并可能需要局部麻醉。(3)压力疗法。这是增生性烧伤疤痕的标准治疗方案,虽然虽然作用机制尚不明确,而且缺少严格的实验证据,但是压力疗法经常在医院里使用。这种特殊的绷带样服装需要连续使用长达12个月。(4)放射疗法。原理:放射线可以穿透人体组织,当它照射到疤痕组织后,其辐射能量向组织传递,使疤痕造成物理和化学损伤,从而抑制、破坏疤痕的生长,达到治疗疤痕的目的。因为有副作用的可能性,放射治疗通常只用来治疗对其它治疗方案无效的成年人疤痕瘤。(5)激光疗法。原理:利用不同波长的彩光作用于不同组织,有选择的进行治疗,保证皮肤不受损伤,光射入皮下,将颗粒变成粉末,使它们之间跳高加大,然后被巨噬细胞吸收和清除,如果疤痕组织颜色较深,可重复多次治疗,不断变换光的波长。激光被用来治疗各种类型的疤痕,但是结果有好有坏。虽然有一些有效的报道,但是作为一种新型治疗方案,激光治疗还缺乏足够的医学证据。(6)冷冻疗法。原理:利用0℃以下的低温,使瘢痕组织在冷冻情况下有效的被破坏,达到永久去疤的目的。用液体氮来冷冻疤痕可能对严重的痘痕有效,但是一些相关的副作用让这种疗法基本上局限于非常小的疤痕。(7)硅胶贴片疗法。原理:自20世纪80年代开始被广泛应用,可有效防治增生性疤痕和疤痕疙瘩。目前较普遍的观点认为硅胶贴的封闭和水化作用使皮肤角质层含水量增加,使疤痕变软、成熟,以达到防治疤痕的目的。一般应用硅胶贴几周后,疤痕质地开始变软,2-3个月后颜色变淡,疤痕变平。随着疤痕的改善,瘙痒、疼痛等症状也大多随之消失。
申请公布号 CN 102139033 A(申请号201110088284.0)的中国专利文献提供了一种治疗孕妇剖腹产术后皮肤创伤的中药组合物,它主要由以下原料制得:黄芪,人参、血竭、黄柏、黄芩、榆树皮、枸杞、乳香、没药、五倍子和甘草。申请公布号 CN 103007249 A(申请号 201310017871.X)的中国专利文献公开了一种疤痕再生修复膏,其制备方法是:将人参,丹参,黄芪,红花,覆盘子,草决明,藤三七,三七,干姜和川芎制成浓缩成稠浸膏;将乳香和没药混配;樟脑粉和薄荷脑共研熔融;将辅料硬脂酸,羊毛脂,黄凡士林和山梨醇制备乳膏;羧甲基纤维素钠溶于蒸馏水中;制备的辅料在水浴锅中混合,搅拌并保持温度在40℃左右,搅拌9小时即可制成疤痕再生修复乳膏;密闭贮藏三个月,开罐后再次搅拌均匀灌装密封即可。申请公布号 CN 102274298 A(申请号201110249020.9)的中国专利文献公开了一种疤痕修复液及其制备方法,制备方法为:(1)取原料大黄和三七;加入乙醇水溶液,加热回流提取得提取液,减压浓缩;(2)取原料五灵脂加入水煎煮,将煎煮液减压浓缩;(3)将步骤(1)和步骤(2)获得的浓缩液合并为总浓缩液,混匀,加入总浓缩液质量的1%~10%的羟丙基三甲基氯化铵壳聚糖或羧甲基壳聚糖,搅拌均匀后,加入总浓缩液质量的1%~3%成膜剂,搅拌均匀,即制成疤痕修复液。
目前对于剖腹产伤口疤痕的修复均存在效果不理想,费用较高、患者比较痛苦、治疗时间长、有副作用等不足。
发明内容
针对现有技术的不足,本发明的目的是提供一种修复剖腹产疤痕的药膏及其制备方法。本发明疗效显著,治疗费用低、无痛苦、治疗时间较短、无副作用。
本发明的技术方案是:
一种修复剖腹产疤痕的药膏,取下述重量配比的主要原料药制备而成:荆芥10-15,金银花10-15,花榈木8-12,艾叶10-15,没药9-16,黄连4-9,蛇床子8-12,密陀僧5-10,大枫子7-12,木鳖子9-15,葱白6-12,土茯苓5-10,醒目薰衣草精油0.5-1.2,橙花精油0.6-1.0。
一种修复剖腹产疤痕的药膏,优选的方案是,取下述重量配比的主要原料药制备而成:荆芥12-14,金银花11-13,花榈木9-11,艾叶11-13,没药12-14,黄连5-8,蛇床子9-11,密陀僧6-8,大枫子9-11,木鳖子11-13,葱白8-10,土茯苓6-8,醒目薰衣草精油0.7-0.9,橙花精油0.7-0.9。
一种修复剖腹产疤痕的药膏,更加优选的方案是,取下述重量配比的主要原料药制备而成:荆芥13,金银花12,花榈木10,艾叶12,没药13,黄连6,蛇床子10,密陀僧7,大枫子10,木鳖子12,葱白9,土茯苓7,醒目薰衣草精油0.8,橙花精油0.8。
上述修复剖腹产疤痕的药膏的制备方法是:
(1)将大枫子放入75℃-95℃的烘箱中,烘2-4小时,将大米与烘烤后的大枫子一同置于药锅内,每100kg大枫子用大米18-30kg,加热拌炒,米炒至黄色为度,取出,筛去米,放凉,研成细粉,过100-140目筛;
(2)将除大枫子、醒目薰衣草精油和橙花精油外的各原料药分别晾干,粉碎至100-140目;
(3)将醒目薰衣草精油和橙花精油混合均匀,然后慢慢加入凡士林中,搅拌均匀;
(4)将步骤(1)和步骤(2)所得充分混匀,用步骤(3)所得调匀成膏,即得。
优选在于步骤(1)中,将大枫子放入80℃-90℃的烘箱中。
优选在于步骤(1)中,烘2.5-3.5小时。
优选在于步骤(1)中,每100kg大枫子用大米20-27kg。
优选在于步骤(1)中,过110-130目筛。
优选在于步骤(2)中,粉碎至110-130目。
更加优选的,步骤(1)中将大枫子放入85℃的烘箱中。
更加优选的,步骤(1)中烘3小时。
更加优选的,步骤(1)中每100kg大枫子用大米24kg。
更加优选的,步骤(1)中过120目筛。
更加优选的,步骤(2)中粉碎至120目。
本发明提供的修复剖腹产疤痕的药膏不含激素、抗生素、无副作用,没有依赖性,安全、有效。除此之外,本发明的优良效果还表现在:
1、制备方法简单;
2、使用方便,只需外涂就能祛疤,无需手术,无痛苦,不影响正常的生活、学习和工作;
3、治疗费用低,无任何风险,无需高昂的治疗费用,能够减轻患者经济负担;
4、治疗时间较短,减轻患者的精神压力;
5、具有清热解毒、活血化瘀、止痛止痒、去腐生肌、消肿散结等功效,能够促进伤口愈合,能帮助细胞再生,增加皮肤弹性,具有愈合疤痕的功效,对于剖腹产疤痕具有良好的修复作用。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
实施例1一种修复剖腹产疤痕的药膏,取下述重量份的主要原料药制备而成(每份为60g):荆芥10份,金银花10份,花榈木8份,艾叶10份,没药9份,黄连4份,蛇床子8份,密陀僧5份,大枫子7份,木鳖子9份,葱白6份,土茯苓5份,醒目薰衣草精油0.5份,橙花精油0.6份。
上述修复剖腹产疤痕的药膏的制备方法是:
(1)将大枫子放入75℃的烘箱中,烘2小时,将大米与烘烤后的大枫子一同置于药锅内,每100kg大枫子用大米18kg,加热拌炒,米炒至黄色为度,取出,筛去米,放凉,研成细粉,过100目筛;
(2)将除大枫子、醒目薰衣草精油(名称:普罗旺斯醒目薰衣草精油,品牌:汇美舍(PrettyValley),生产商:广州美然化妆品厂)和橙花精油(货号:11534,生产商:广州天玺生物科技有限公司)外的各原料药分别晾干,粉碎至100目;
(3)将醒目薰衣草精油和橙花精油混合均匀,然后慢慢加入凡士林中,搅拌均匀;
(4)将步骤(1)和步骤(2)所得充分混匀,用步骤(3)所得调匀成膏,即得。
本发明所得修复剖腹产疤痕的药膏的使用方法是:取适量药膏均匀涂抹于患处按摩3分钟,每天早晚各涂抹1次。
实施例2一种修复剖腹产疤痕的药膏,取下述重量份的主要原料药制备而成(每份为60g):荆芥15份,金银花15份,花榈木12份,艾叶15份,没药16份,黄连9份,蛇床子12份,密陀僧10份,大枫子12份,木鳖子15份,葱白12份,土茯苓10份,醒目薰衣草精油1.2份,橙花精油1.0份。
上述修复剖腹产疤痕的药膏的制备方法是:
(1)将大枫子放入95℃的烘箱中,烘4小时,将大米与烘烤后的大枫子一同置于药锅内,每100kg大枫子用大米30kg,加热拌炒,米炒至黄色为度,取出,筛去米,放凉,研成细粉,过140目筛;
(2)将除大枫子、醒目薰衣草精油(名称:普罗旺斯醒目薰衣草精油,品牌:汇美舍(PrettyValley),生产商:广州美然化妆品厂)和橙花精油(货号:11534,生产商:广州天玺生物科技有限公司)外的各原料药分别晾干,粉碎至140目;
(3)将醒目薰衣草精油和橙花精油混合均匀,然后慢慢加入凡士林中,搅拌均匀;
(4)将步骤(1)和步骤(2)所得充分混匀,用步骤(3)所得调匀成膏,即得。
典型病例一:XXX,女,28岁。剖腹产手术后2年。疤痕长度16cm,宽度为1.2cm,疤痕有明显凸起症状,凸起高度为0.18cm,疤痕颜色是暗红色,疤痕表皮可以看到明显的毛细血管扩张,而且伴有痛痒症状,特别是衣服摩擦疤痕时,痛痒症状更是明显。曾经涂抹药物治疗半年,效果不明显。使用本实施例所得修复剖腹产疤痕的药膏,取适量药膏均匀涂抹于患处按摩3分钟,每天早晚各涂抹1次。使用半个月,痛痒症状消失,疤痕有了改善。继续使用两个月,疤痕变平,软,呈一线状。
实施例3一种修复剖腹产疤痕的药膏,取下述重量份的主要原料药制备而成(每份为60g):荆芥12份,金银花11份,花榈木9份,艾叶11份,没药12份,黄连5份,蛇床子9份,密陀僧6份,大枫子9份,木鳖子11份,葱白8份,土茯苓6份,醒目薰衣草精油0.7份,橙花精油0.7份。
上述修复剖腹产疤痕的药膏的制备方法是:
(1)将大枫子放入80℃的烘箱中,烘2.5小时,将大米与烘烤后的大枫子一同置于药锅内,每100kg大枫子用大米20kg,加热拌炒,米炒至黄色为度,取出,筛去米,放凉,研成细粉,过110目筛;
(2)将除大枫子、醒目薰衣草精油(名称:普罗旺斯醒目薰衣草精油,品牌:汇美舍(PrettyValley),生产商:广州美然化妆品厂)和橙花精油(货号:11534,生产商:广州天玺生物科技有限公司)外的各原料药分别晾干,粉碎至110目;
(3)将醒目薰衣草精油和橙花精油混合均匀,然后慢慢加入凡士林中,搅拌均匀;
(4)将步骤(1)和步骤(2)所得充分混匀,用步骤(3)所得调匀成膏,即得。
典型病例二:XXX,女,30岁。剖腹产手术后2年。2年前患者剖腹生下一个儿子,经过产后的锻炼,虽然恢复了产前苗条的身材,可是剖腹疤痕却是留下来了,并伴有痛痒不适感。曾经使用祛疤贴、消疤液等均无效。使用本实施例所得修复剖腹产疤痕的药膏,取适量药膏均匀涂抹于患处,每天早晚各涂抹1次。使用20天,痛痒症状消失,疤痕有了明显的淡化。继续使用1个月,腹部上的疤痕变平,软,呈一线状。随访未见复发。
实施例4一种修复剖腹产疤痕的药膏,取下述重量份的主要原料药制备而成(每份为60g):荆芥14份,金银花13份,花榈木11份,艾叶13份,没药14份,黄连8份,蛇床子11份,密陀僧8份,大枫子11份,木鳖子13份,葱白10份,土茯苓8份,醒目薰衣草精油0.9份,橙花精油0.9份。
上述修复剖腹产疤痕的药膏的制备方法是:
(1)将大枫子放入90℃的烘箱中,烘3.5小时,将大米与烘烤后的大枫子一同置于药锅内,每100kg大枫子用大米27kg,加热拌炒,米炒至黄色为度,取出,筛去米,放凉,研成细粉,过130目筛;
(2)将除大枫子、醒目薰衣草精油(名称:普罗旺斯醒目薰衣草精油,品牌:汇美舍(PrettyValley),生产商:广州美然化妆品厂)和橙花精油(货号:11534,生产商:广州天玺生物科技有限公司)外的各原料药分别晾干,粉碎至130目;
(3)将醒目薰衣草精油和橙花精油混合均匀,然后慢慢加入凡士林中,搅拌均匀;
(4)将步骤(1)和步骤(2)所得充分混匀,用步骤(3)所得调匀成膏,即得。
典型病例三: XXX,女,34岁。患者剖腹产手术后3年,腹部形成凹陷疤痕,而且伴有痛痒不适感。曾经使用过消痕液、祛疤贴等,均未见好转。在闺蜜的推荐下,使用本实施例所得修复剖腹产疤痕的药膏,取适量药膏均匀涂抹于患处按摩3分钟,每天早晚各涂抹1次。使用半个月,痛痒症状消失,疤痕有了改善。继续使用2个月,疤痕完全平复,疤痕不明显。随访未见复发。
实施例5一种修复剖腹产疤痕的药膏,取下述重量份的主要原料药制备而成(每份为60g):荆芥13份,金银花12份,花榈木10份,艾叶12份,没药13份,黄连6份,蛇床子10份,密陀僧7份,大枫子10份,木鳖子12份,葱白9份,土茯苓7份,醒目薰衣草精油0.8份,橙花精油0.8份。
上述修复剖腹产疤痕的药膏的制备方法是:
(1)将大枫子放入85℃的烘箱中,烘3小时,将大米与烘烤后的大枫子一同置于药锅内,每100kg大枫子用大米24kg,加热拌炒,米炒至黄色为度,取出,筛去米,放凉,研成细粉,过120目筛;
(2)将除大枫子、醒目薰衣草精油(名称:普罗旺斯醒目薰衣草精油,品牌:汇美舍(PrettyValley),生产商:广州美然化妆品厂)和橙花精油(货号:11534,生产商:广州天玺生物科技有限公司)外的各原料药分别晾干,粉碎至120目;
(3)将醒目薰衣草精油和橙花精油混合均匀,然后慢慢加入凡士林中,搅拌均匀;
(4)将步骤(1)和步骤(2)所得充分混匀,用步骤(3)所得调匀成膏,即得。
本发明所用主要中药原料的药理如下:
荆芥:基原:为唇科植物裂叶荆芥和多裂叶荆芥的茎叶和花穗。药性:辛、微苦,微湿。归肺、肝经。功用主治:祛风,解表,透疹,止血。主感冒发热,头痛,目痒,咳嗽,咽喉肿痛,麻疹,痈肿,疮疥,衄血,吐血,便血,崩漏,产后血晕。
金银花:基原:为忍冬科植物忍冬的花蕾。化学成份:花含木犀草素、肌醇约1%及皂甙、鞣质等。药性:甘,寒。归肺、胃经。功用主治:清热,解毒。治温病发热,热毒血痢,痈疡,肿毒,瘰疬,痔漏。
花榈木:又名“花狸”、花梨木。基原:豆科红豆树属植物花榈木,以根、根皮、茎及叶入药。药性:辛,温,有毒。功用主治:活血化瘀,祛风消肿。用于跌打损伤,腰肌劳损,风湿关节痛,产后血瘀疼痛,白带,流行性腮腺炎,丝虫病,根皮外用治骨折,叶外用治烧烫伤。
艾叶:基原:为菊科植物艾的叶。药性:味辛,苦,性温。归肝、脾、肾经。功用主治:温经止血,散寒止痛,祛湿止痒。主吐血,衄血,吃力血,便血,便血,崩漏,妊娠下血,月经不调,痛经,胎动不安,心腹冷痛,泄泻久痢,霍乱转筋,带下,湿疹,疥癣,痔疮,痈疡。
没药:基原:为橄榄科植物没药树及同属植物树干皮部渗出的油胶树脂。药性:苦,平。归肝、脾、心、肾经。功用主治:活血止痛,消肿生肌。主胸腹瘀痛,痛经,经闭,症瘕,跌打损伤,痈肿疮疡,肠痈,目赤肿痛。
黄连:别名:味连、川连、鸡爪连,基原:为毛茛科植物黄连、三角叶黄连或云连的干燥根茎。药性:苦,寒。归心、脾、胃、肝、胆、大肠经。功用主治:清热燥湿,泻火解毒。用于寒热互结,湿热中阻,痞满呕吐。萸黄连舒肝和胃止呕。用于肝胃不和,呕吐吞酸。
蛇床子:基原:本品为伞形科植物蛇床的干燥成熟果实。药性:辛、苦,温,有小毒。归肾经。功用主治:温肾壮阳,燥湿,祛风,杀虫。用于阳痿,宫冷,寒湿带下,湿痹腰痛,外治外阴湿疹,妇人阴痒,滴虫性阴道炎。
密陀僧:基原:为硫化物类方铅矿族矿物方铅矿提炼银、铅时沉积的炉底,或为铅熔融后的加工制成品。成分:主要含氧化铅;尚含少量砂石、金属铅、二氧化铅等夹杂物,以及微量铅、锑、铁、钙、镁等。药性:咸、辛,平,有毒。归肝、脾经。功用主治:燥湿,杀虫,解毒,收敛,防腐。主治疮疡溃烂久不收敛,口疮,湿疹,疥癣,狐臭,汗斑,酒皶鼻,烧烫伤。宜忌:本品以外用为主,长期大量使用易引起铅中毒。内服宜慎,不可过量,不能超过一星期,体虚及孕妇、儿童禁服。
大枫子:基原:为大枫子科植物大风子的成熟种子。药性:辛,热,有毒。归肺、肝经。功用主治:祛风燥湿,攻毒杀虫。主治麻风,外用治梅疮,疥癣,手背皲裂等症。
木鳖子:基原:为葫芦科植物木鳖子的种子。药性:味甘,温,无毒。归肝、脾、胃经。功用主治:消肿散结,解毒,追风止痛。主痈肿,疔疮,无名肿毒,痔疮,癣疮,粉刺,默黑,乳腺炎,淋巴结结核,痢疾,风湿痹痛,筋脉拘挛,牙龈肿痛。
葱白:基原:为百合科植物葱的鳞茎。药性:辛,温。归肺、胃经。功用主治:发表,通阳,解毒。主治感冒风寒,阴寒腹痛,二便不通,痢疾,痈肿肿痛,虫积腹痛。
土茯苓:基原:为百合科菝葜属植物光叶菝葜的根茎。成分:根茎含挥发油类:正十六酸甲酯等49种成分;酚酸类:3-0-咖啡酰莽草酸,阿魏酸;甾体皂苷,黄酮苷等。药性:甘、淡,平。归肝、肾、脾、胃经。功用主治:清热除湿,泄浊解毒,通利关节。主治梅毒,淋浊,泄泻,筋骨挛痛,脚气,痈肿,疮癣,瘰疬,瘿瘤及汞中毒。
醒目薰衣草精油:醒目薰衣草精油是从薰衣草与其杂交种的杂交品种植物中提取的。主要成分:芳樟醇、乙酸芳樟酯、樟脑、桉树脑、莰烯、二戊烯、柠檬油精、罗勒烯和萜品烯。功效:(1)心灵疗效:使疲惫的心灵焕然一新。(2)身体疗效:特别有益于肌肉疼痛与肌肉僵硬,也能帮助风湿的不适和不灵活的关节。对呼吸道颇有好处,尤其是像咳嗽、感冒与流行感冒等毛病。当肺部和鼻窦被浓痰与鼻涕堵塞时,醒目薰衣草可以使呼吸顺畅。(3)皮肤疗效:促进伤口结疤,有助于伤口愈合。
橙花精油:橙花精油是从苦橙白色花瓣中提取的。橙花精油的主要化学成分 为α-蒎烯、莰烯、β-蒎烯、α-萜品烯、橙花醇、橙花醇乙酸酯、金合欢醇、酸酯和吲哚。橙花精油的功效与作用:抗沮丧、抗菌、抗痉挛、催情、杀菌、祛肠胃胀气、使兴奋、增进细胞活力、除臭、帮助消化、柔软皮肤、镇定、补身。苦橙花精油具有抗忧郁、杀菌、抗痉挛和催情的效果,也有温和的安神作用。最重要的是它可以缓解情绪引起的各种病症,比如面试、考试或者演讲前出现的焦虑症等。橙花精油的应用:(1)护肤保养:橙花精油因能增强细胞活力的特性,能帮助细胞再生,增加皮肤弹性。适合干性、敏感及成熟型肌肤使用,对于其他的皮肤问题橙花精油也有帮助,特别是螺旋状的静脉曲张、疤痕及妊辰纹。在照X光时,橙花精油可用来保护皮肤。(2)身体保养:对身体而已,橙花精油是一种非常好的补品。橙花精油能镇定副交感神经,可以用来治疗失眠,尤其是在沮丧不得入眠的情况下。还能改善神经痛、头痛和眩晕,能止住接连不断的呵欠。橙花精油有催情功效,能镇抚焦躁的状态。橙花精油抗痉挛的特性可以用来安抚肠胃,对结肠炎和腹泻也有效果。镇定心悸、清血、促进循环。橙花精油还能改善沮丧的情绪,如经前症候群及更年期的心理问题。(3)心理保养:橙花精油可以使人精神愉快,可减轻长期的焦虑、沮丧和压力。橙花还具有惊人的安抚心灵的作用。(4)家具日用:橙花精油适合在睡前的卧房使用,有很好的镇静安眠效果,能彻底消除疲劳释放压力,安定急躁的情绪,味道甜美舒适,有给人定下心来,享受瞬间的快乐的感觉,具有安定神经,镇定心悸、抗痉挛的作用。
试验例1:为了验证本发明所得修复剖腹产疤痕的药膏(实施例5)的药效,我们进行了对比试验。2008年10月-2012年1月,在4所医院筛选266例剖腹产术后皮肤创伤患者,年龄23-36岁,随机分为实验组133例,对照组133例。治疗方法:实验组使用本发明所得修复剖腹产疤痕的药膏,使用方法是:取适量药膏均匀涂抹于患处按摩3分钟,每天早晚各涂抹1次。对照组使用澳福来美丽疤痕膏、疤痕疙瘩灵、消痕液、祛疤贴等。疗效判断标准:痊愈:痛痒症状消失,疤痕变扁平,变软,原手术切口呈一条细线;显效:痛痒症状消失,疤痕软化,伤口大部分变平;好转:痛痒症状减轻,伤口部分变平;无效:痛痒症状和疤痕外观,质地未见明显改善。总有效包括治愈和显效。治疗2个月,结果如表1所示。
表1:本发明所得修复剖腹产疤痕的药膏效果验证[例(%)]
治疗效果:在实验组的133例患者中,治愈110例,占82.71%;显效21例,占15.79%;好转1例,占0.75%;无效1例,占0.75%,总有效率达98.5%。在对照组的133例患者中,治愈70例,占52.63%;显效27例,占20.30%;好转26例,占19.55%;无效10例,占7.52%,总有效率72.93%。实验组总有效率明显优于对照组,两组比较差异有显著性。
本发明选择荆芥、金银花、花榈木和艾叶等为主要原料,制成修复剖腹产疤痕的药膏。方中荆芥祛风,解表,透疹,止血。金银花清热,解毒。花榈木活血化瘀,祛风消肿。艾叶温经止血,散寒止痛,祛湿止痒。没药活血止痛,消肿生肌。黄连清热燥湿,泻火解毒。蛇床子温肾壮阳,燥湿,祛风,杀虫。密陀僧燥湿,杀虫,解毒,收敛,防腐。大枫子祛风燥湿,攻毒杀虫。木鳖子消肿散结,解毒,追风止痛。葱白发表,通阳,解毒。土茯苓清热除湿,泄浊解毒,通利关节。醒目薰衣草精油能够促进伤口结疤,有助于伤口愈合。橙花精油因能增强细胞活力的特性,能帮助细胞再生,增加皮肤弹性,具有愈合疤痕的功效。诸药合用,具有清热解毒、活血化瘀、止痛止痒、去腐生肌、消肿散结等功效,能够促进伤口愈合,能帮助细胞再生,增加皮肤弹性,具有愈合疤痕的功效,对于剖腹产疤痕具有良好的修复作用。
最后应说明的是,实施例只是本发明最优的具体实施方式而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (9)
1.一种修复剖腹产疤痕的药膏,其特征在于,取下述重量配比的主要原料药制备而成:荆芥10-15,金银花10-15,花榈木8-12,艾叶10-15,没药9-16,黄连4-9,蛇床子8-12,密陀僧5-10,大枫子7-12,木鳖子9-15,葱白6-12,土茯苓5-10,醒目薰衣草精油0.5-1.2,橙花精油0.6-1.0。
2.如权利要求1所述的修复剖腹产疤痕的药膏,其特征在于,取下述重量配比的主要原料药制备而成:荆芥12-14,金银花11-13,花榈木9-11,艾叶11-13,没药12-14,黄连5-8,蛇床子9-11,密陀僧6-8,大枫子9-11,木鳖子11-13,葱白8-10,土茯苓6-8,醒目薰衣草精油0.7-0.9,橙花精油0.7-0.9。
3.如权利要求1所述的修复剖腹产疤痕的药膏,其特征在于,取下述重量配比的主要原料药制备而成:荆芥13,金银花12,花榈木10,艾叶12,没药13,黄连6,蛇床子10,密陀僧7,大枫子10,木鳖子12,葱白9,土茯苓7,醒目薰衣草精油0.8,橙花精油0.8。
4.如权利要求1~3任一所述的修复剖腹产疤痕的药膏的制备方法,其特征在于,步骤如下:
(1)将大枫子放入75℃-95℃的烘箱中,烘2-4小时,将大米与烘烤后的大枫子一同置于药锅内,每100kg大枫子用大米18-30kg,加热拌炒,米炒至黄色为度,取出,筛去米,放凉,研成细粉,过100-140目筛;
(2)将除大枫子、醒目薰衣草精油和橙花精油外的各原料药分别晾干,粉碎至100-140目;
(3)将醒目薰衣草精油和橙花精油混合均匀,然后慢慢加入凡士林中,搅拌均匀;
(4)将步骤(1)和步骤(2)所得充分混匀,用步骤(3)所得调匀成膏,即得。
5.如权利要求4所述的修复剖腹产疤痕的药膏的制备方法,其特征在于,步骤(1)中将大枫子放入80℃-90℃的烘箱中(优选将大枫子放入85℃的烘箱中)。
6.如权利要求4所述的修复剖腹产疤痕的药膏的制备方法,其特征在于,步骤(1)中烘2.5-3.5小时(优选烘3小时)。
7.如权利要求4所述的修复剖腹产疤痕的药膏的制备方法,其特征在于,步骤(1)中每100kg大枫子用大米20-27kg(优选每100kg大枫子用大米24kg)。
8.如权利要求4所述的修复剖腹产疤痕的药膏的制备方法,其特征在于,步骤(1)中过110-130目筛(优选过120目筛)。
9.如权利要求4所述的修复剖腹产疤痕的药膏的制备方法,其特征在于,步骤(2)中粉碎至110-130目(优选粉碎至120目)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510043395.8A CN104587319A (zh) | 2015-01-29 | 2015-01-29 | 一种修复剖腹产疤痕的药膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510043395.8A CN104587319A (zh) | 2015-01-29 | 2015-01-29 | 一种修复剖腹产疤痕的药膏 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104587319A true CN104587319A (zh) | 2015-05-06 |
Family
ID=53113590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510043395.8A Pending CN104587319A (zh) | 2015-01-29 | 2015-01-29 | 一种修复剖腹产疤痕的药膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104587319A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105456578A (zh) * | 2016-01-15 | 2016-04-06 | 李丽 | 一种治疗疤痕的中药膏剂及其制备方法 |
CN107029219A (zh) * | 2017-06-04 | 2017-08-11 | 重庆华邦医美科技有限公司 | 一种促进皮肤组织再生的药膏 |
-
2015
- 2015-01-29 CN CN201510043395.8A patent/CN104587319A/zh active Pending
Non-Patent Citations (3)
Title |
---|
段翠翠: "《女人这样做吃不胖、晒不黑、人不老》", 30 September 2013, 天津科学技术出版社 * |
胡献国 等: "《中国膏药配方配制全书》", 30 April 2014, 辽宁科学技术出版社 * |
齐红莉 等: "谷胱肝肽配合理肤泉水、香熏疗法治疗面部炎症后色素沉着疗效观察", 《中国美容医学》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105456578A (zh) * | 2016-01-15 | 2016-04-06 | 李丽 | 一种治疗疤痕的中药膏剂及其制备方法 |
CN107029219A (zh) * | 2017-06-04 | 2017-08-11 | 重庆华邦医美科技有限公司 | 一种促进皮肤组织再生的药膏 |
CN107029219B (zh) * | 2017-06-04 | 2021-03-23 | 重庆玛恩医疗美容医院有限公司 | 一种促进皮肤组织再生的药膏 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105146094A (zh) | 一种中草药添加剂及其配制方法 | |
CN104353019A (zh) | 舒经调脏的中药热敷袋及其制备方法 | |
CN107184782A (zh) | 外用中药组合物、制备方法及其应用 | |
CN105998901A (zh) | 一种治疗肝气郁结的中药饮品及制备方法 | |
CN104587319A (zh) | 一种修复剖腹产疤痕的药膏 | |
CN103007207A (zh) | 一种防治鸭传染性浆膜炎的中药 | |
CN103768275A (zh) | 一种治疗脂溢性脱发的中药生发液 | |
CN103845616A (zh) | 一种消炎杀菌的药物组合物 | |
CN108272986A (zh) | 一种草本泡澡粉 | |
CN103638475A (zh) | 一种治疗乳癖的中药喷雾剂及其制备方法 | |
CN102258602B (zh) | 治疗风湿、类风湿的中药组合物及其制备方法 | |
CN102204977B (zh) | 治疗输卵管不通的外用药膏组合物的制备方法及其应用 | |
CN1044443C (zh) | 肛肠疾病薰浴剂 | |
CN104984122A (zh) | 治疗破伤风的中药剂及其制备方法 | |
CN104740443A (zh) | 一种中药复方精油 | |
CN115887601B (zh) | 一种用于痔疮的组合物及其制备方法 | |
CN104147580A (zh) | 一种治疗骨质增生的艾条 | |
CN1994380A (zh) | 治疗痹症的外用中药药物及其热敷袋和制备方法 | |
CN1048632C (zh) | 一种祛风湿、止痹痛的外用药及其制备方法 | |
CN1052909C (zh) | 一种治疗骨质增生病的药物 | |
CN106310172A (zh) | 一种治疗疼痛性疾病的膏泥膜药物及其制备方法和用途 | |
CN105456708A (zh) | 一种用于治疗口唇炎的药物及其制备方法 | |
CN104840793A (zh) | 用于小儿高热的纯中药退烧贴及其制备方法 | |
CN104547157A (zh) | 修复剖腹产伤口疤痕的外敷剂及制备方法 | |
CN103550353A (zh) | 治疗大腿内侧股癣的中药外用搽剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 714000 Weinan province Shaanxi city Linwei District People's Street No. seventy-four Jinmao District 6-2-901 Applicant after: Chen Wenbin Address before: 250000 Shandong province Ji'nan City flyover District Dikou Road No. 110 Applicant before: Chen Wenbin |
|
COR | Change of bibliographic data | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150506 |